Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Covalent inhibitors: a rational approach to drug discovery
Fandi Sutanto, Markella Konstantinidou, Alexander Dömlingꝉ
RSC Medicinal Chemistry (2020) Vol. 11, Iss. 8, pp. 876-884
Open Access | Times Cited: 298

Showing 1-25 of 298 citing articles:

Therapeutic peptides: current applications and future directions
Lei Wang, Nanxi Wang, Wenping Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 1182
Advances in covalent drug discovery
Lydia Boike, Nathaniel J. Henning, Daniel K. Nomura
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 12, pp. 881-898
Open Access | Times Cited: 481
Bicyclobutanes: from curiosities to versatile reagents and covalent warheads
Christopher B. Kelly, John A. Milligan, Leon J. Tilley, et al.
Chemical Science (2022) Vol. 13, Iss. 40, pp. 11721-11737
Open Access | Times Cited: 156
Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 156
Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective
Yang Yang, Shuo Li, Yujiao Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 144
Imidazoles as Potential Anticancer Agents: An Update on Recent Studies
Pankaj Sharma, Chris LaRosa, Janet Antwi, et al.
Molecules (2021) Vol. 26, Iss. 14, pp. 4213-4213
Open Access | Times Cited: 130
The importance of sulfur-containing motifs in drug design and discovery
Muhamad Mustafa, Jean‐Yves Winum
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 5, pp. 501-512
Closed Access | Times Cited: 126
Fragment-based covalent ligand discovery
Wenchao Lu, Milka Kostić, Tinghu Zhang, et al.
RSC Chemical Biology (2021) Vol. 2, Iss. 2, pp. 354-367
Open Access | Times Cited: 107
Allosteric Regulation of IGF2BP1 as a Novel Strategy for the Activation of Tumor Immune Microenvironment
Yang Liu, Qiang Guo, Heng Yang, et al.
ACS Central Science (2022) Vol. 8, Iss. 8, pp. 1102-1115
Open Access | Times Cited: 88
Targeting the PI3K/AKT/mTOR Signaling Pathway in the Treatment of Human Diseases: Current Status, Trends, and Solutions
Jindi Huang, Liye Chen, Jiangxia Wu, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 24, pp. 16033-16061
Closed Access | Times Cited: 75
Strategies for designing proteolysis targeting chimaeras (PROTACs)
Shipeng He, Guoqiang Dong, Junfei Cheng, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 3, pp. 1280-1342
Closed Access | Times Cited: 74
Covalent targeted radioligands potentiate radionuclide therapy
Xi‐Yang Cui, Zhu Li, Ziren Kong, et al.
Nature (2024) Vol. 630, Iss. 8015, pp. 206-213
Closed Access | Times Cited: 54
Profiling Sulfur(VI) Fluorides as Reactive Functionalities for Chemical Biology Tools and Expansion of the Ligandable Proteome
Katharine Gilbert, Aini Vuorinen, Arron Aatkar, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 2, pp. 285-295
Open Access | Times Cited: 43
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities
Marco Robello, Elisabetta Barresi, Emma Baglini, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 7, pp. 3508-3545
Open Access | Times Cited: 82
Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge
Francesca Picarazzi, Ilaria Vicenti, Francesco Saladini, et al.
Molecules (2020) Vol. 25, Iss. 23, pp. 5695-5695
Open Access | Times Cited: 80
An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 Mpro inhibitor
Daniel Zaidman, Paul Gehrtz, Mihajlo Filep, et al.
Cell chemical biology (2021) Vol. 28, Iss. 12, pp. 1795-1806.e5
Open Access | Times Cited: 73
Recent advances in the development of covalent inhibitors
Hyunsoo Kim, Yoon Soo Hwang, Mingi Kim, et al.
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 7, pp. 1037-1045
Open Access | Times Cited: 65
Flavonoids in Ampelopsis grossedentata as covalent inhibitors of SARS-CoV-2 3CLpro: Inhibition potentials, covalent binding sites and inhibitory mechanisms
Yuan Xiong, Guanghao Zhu, Yani Zhang, et al.
International Journal of Biological Macromolecules (2021) Vol. 187, pp. 976-987
Open Access | Times Cited: 61
Advances in the application of immobilized enzyme for the remediation of hazardous pollutant: A review
P.R. Yaashikaa, M. Keerthana Devi, P. Senthil Kumar
Chemosphere (2022) Vol. 299, pp. 134390-134390
Closed Access | Times Cited: 53
Lessons Learned from Past Cyclin-Dependent Kinase Drug Discovery Efforts
Zhouling Xie, Shuzeng Hou, Xiaoxiao Yang, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 9, pp. 6356-6389
Closed Access | Times Cited: 46
Nitriles: an attractive approach to the development of covalent inhibitors
Vinícius Bonatto, Rafael F. Lameiro, Fernanda dos Reis Rocho, et al.
RSC Medicinal Chemistry (2022) Vol. 14, Iss. 2, pp. 201-217
Open Access | Times Cited: 42
USP7-Based Deubiquitinase-Targeting Chimeras Stabilize AMPK
Jing Liu, Xiaoping Hu, Kaixiu Luo, et al.
Journal of the American Chemical Society (2024)
Closed Access | Times Cited: 11
Recent Advances on Targeting Proteases for Antiviral Development
Pedro Henrique Oliveira Borges, Sabrina Baptista Ferreira, Floriano Paes Silva
Viruses (2024) Vol. 16, Iss. 3, pp. 366-366
Open Access | Times Cited: 10
Clinical applications of fibroblast activation protein inhibitor positron emission tomography (FAPI-PET)
Yuriko Mori, Emil Novruzov, Dominik Schmitt, et al.
npj Imaging (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 9
High-Throughput Hit Identification with Acoustic Ejection Mass Spectrometry
Xiujuan Wen, David G. McLaren
SLAS TECHNOLOGY (2025), pp. 100245-100245
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top